17 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
Gilead to Collaborate with Novo Nordisk for NASH Treatment http://www.zacks.com/stock/news/381020/gilead-to-collaborate-with-novo-nordisk-for-nash-treatment?cid=CS-ZC-FT-381020 Apr 15, 2019 - Gilead Sciences (GILD) will collaborate with Novo Nordisk to develop treatments for liver disease, NASH.
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal http://www.zacks.com/stock/news/382518/biotech-stock-roundup-gild-collaborates-on-nash-fcsc-surges-on-deal?cid=CS-ZC-FT-382518 Apr 17, 2019 - Key highlights of the past week are collaborations and pipeline updates.
What's in Store for Bayer (BAYRY) This Earnings Season? http://www.zacks.com/stock/news/390421/whats-in-store-for-bayer-bayry-this-earnings-season?cid=CS-ZC-FT-390421 Apr 22, 2019 - Bayer (BAYRY) is expected to provide pipeline updates along with its first-quarter results.
What's in Store for BioSpecifics (BSTC) This Earnings Season? http://www.zacks.com/stock/news/405553/whats-in-store-for-biospecifics-bstc-this-earnings-season?cid=CS-ZC-FT-405553 Apr 30, 2019 - BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.
What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? http://www.zacks.com/stock/news/405507/whats-in-store-for-ani-pharmaceuticals-anip-q1-earnings?cid=CS-ZC-FT-405507 Apr 30, 2019 - ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
Why Earnings Season Could Be Great for Novo Nordisk (NVO) http://www.zacks.com/stock/news/407395/why-earnings-season-could-be-great-for-novo-nordisk-nvo?cid=CS-ZC-FT-407395 May 02, 2019 - Novo Nordisk (NVO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Cards for AEterna (AEZS) This Earnings Season? http://www.zacks.com/stock/news/407877/whats-in-the-cards-for-aeterna-aezs-this-earnings-season?cid=CS-ZC-FT-407877 May 02, 2019 - AEterna (AEZS) may provide update on the path forward for Macrilen in Europe on the first-quarter earnings call.
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug https://www.fool.com/investing/2019/05/09/novo-nordisk-trots-along-waiting-for-its-next-gene.aspx?source=iedfolrf0000001 May 09, 2019 - Oral semaglutide is on its way.
Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug http://www.zacks.com/stock/news/412433/pharma-stock-roundup-agn-nvo-report-q1-earnings-nvs-to-buy-takedas-eye-drug?cid=CS-ZC-FT-412433 May 10, 2019 - Allergan (AGN) and Novo Nordisk (NVO) announce Q1 results. Novartis buys rights to Takeda's dry eye disease drug, Xiidra.
GILD, NVO, ZYNE and NOG among notable after hour movers https://seekingalpha.com/news/3465165-gild-nvo-zyne-nog-among-notable-hour-movers?source=feed_news_all May 17, 2019 - Top Gainers: GILD +3.1%. NOG +3.2%. NBRV +2.7%. GOL +2.3%. NIO +1%.Top Losers: LTM -4.7%. SIGA -1.9%. NKTR -1.8%. NVO -1.7%. ZYNE -1.7%.

Pages: 12

Page 1